Literature DB >> 19466557

Beta2-microglobulin as a potential factor for the expansion of mesenchymal stem cells.

Ying Zhu1, Yongping Su, Tianmin Cheng, Leland W K Chung, Chunmeng Shi.   

Abstract

Multipotent mesenchymal stem cells (MSCs) hold great promise in regenerative medicine, but one of the biggest challenges facing for their application is the ex vivo expansion to obtain enough undifferentiated cells. Fetal bovine serum (FBS), which can elicit possible contaminations of prion, virus, zoonosis or immunological reaction against xenogenic serum antigens, still remains essential to the culture formulations. There is an urgent need to identify potential factors for the undifferentiated expansion of MSCs to reduce the use of FBS or eventually replace it. A previously recognized housekeeping gene, beta2-microglobulin (beta2M), is demonstrated to act as a novel growth factor to stimulate the undifferentiated ex vivo expansion and preserve the pluripotency of adult MSCs from various sources. The use of beta2M might have promising implications for future clinical application of MSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466557      PMCID: PMC2984555          DOI: 10.1007/s10529-009-0027-0

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  20 in total

1.  Beta2-microglobulin as a potential initiator of inflammatory responses.

Authors:  Jin Xie; Qing Yi
Journal:  Trends Immunol       Date:  2003-05       Impact factor: 16.687

2.  Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells.

Authors:  Kenichi Tamama; Vivian H Fan; Linda G Griffith; Harry C Blair; Alan Wells
Journal:  Stem Cells       Date:  2005-09-08       Impact factor: 6.277

3.  Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.

Authors:  Norbert Stute; Katja Holtz; Michael Bubenheim; Claudia Lange; Felix Blake; Axel R Zander
Journal:  Exp Hematol       Date:  2004-12       Impact factor: 3.084

Review 4.  Mesenchymal stem cells in health and disease.

Authors:  Antonio Uccelli; Lorenzo Moretta; Vito Pistoia
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

5.  Immunoreactivity and proliferative actions of beta 2 microglobulin on human bone-derived cells in vitro.

Authors:  D B Evans; M Thavarajah; J A Kanis
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

6.  Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells.

Authors:  Jin Xie; Ying Wang; Muta E Freeman; Bart Barlogie; Qing Yi
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  A bone-derived growth factor isolated from rat calvariae is beta 2 microglobulin.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  Endocrinology       Date:  1987-09       Impact factor: 4.736

8.  Beta(2)-microglobulin as a negative growth regulator of myeloma cells.

Authors:  Rui Min; Zhongkui Li; Joshua Epstein; Bart Barlogie; Qing Yi
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998

9.  Dkk-1-mediated expansion of adult stem cells.

Authors:  Edwin M Horwitz
Journal:  Trends Biotechnol       Date:  2004-08       Impact factor: 19.536

10.  Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.

Authors:  D R Rowley; T D Dang; L McBride; M J Gerdes; B Lu; M Larsen
Journal:  Cancer Res       Date:  1995-02-15       Impact factor: 12.701

View more
  4 in total

1.  β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

Authors:  Sajni Josson; Takeo Nomura; Jen-Tai Lin; Wen-Chin Huang; Daqing Wu; Haiyen E Zhau; Majd Zayzafoon; M Neale Weizmann; Murali Gururajan; Leland W K Chung
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

2.  GAPDH, β-actin and β2-microglobulin, as three common reference genes, are not reliable for gene expression studies in equine adipose- and marrow-derived mesenchymal stem cells.

Authors:  Fatemeh Nazari; Abbas Parham; Adham Fani Maleki
Journal:  J Anim Sci Technol       Date:  2015-05-07

3.  β2-microglobulin is overexpressed in buccal cells of elderly and correlated with expression of p16 and inflammatory genes.

Authors:  Mohammad Althubiti
Journal:  Saudi J Biol Sci       Date:  2022-08-19       Impact factor: 4.052

Review 4.  β2-Microglobulin-mediated signaling as a target for cancer therapy.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Sajni Josson; Hiromitsu Mimata; Leland W K Chung
Journal:  Anticancer Agents Med Chem       Date:  2014-03       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.